Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

The problem of medicating women like the men: Conceptual discussion of menstrual cycle-dependent psychopharmacology

Full metadata record
DC Field Value Language
dc.contributor.authorYum, S.K.-
dc.contributor.authorYum, S.Y.-
dc.contributor.authorKim, T.-
dc.date.accessioned2021-09-02T01:21:10Z-
dc.date.available2021-09-02T01:21:10Z-
dc.date.created2021-06-17-
dc.date.issued2019-
dc.identifier.issn2289-0882-
dc.identifier.urihttps://scholar.korea.ac.kr/handle/2021.sw.korea/70779-
dc.description.abstractWhile hormonal changes during the ovulatory cycles affect multiple body systems, medical management, including medication dosing remains largely uniform between the sexes. Little is known about sex-specific pharmacology in women. Although hormonal fluctuations of the normal menstruating process alters women’s physiology and brain biochemistry, medication dosing does not consider such cyclical changes. Using schizophrenia as an example, this paper illustrates how a woman’s clinical symptoms can change throughout the ovulatory cycle, leading to fluctuations in medication responses. Effects of sex steroids on the brain, clinical pharmacology are discussed. Effective medication dose may be different at different phases of the menstrual cycle. Further research is needed to better understand optimal treatment strategies in reproductive women; we present a potential clinical trial design for examining optimal medication dosing strategies for conditions that have menstruation related clinical fluctuations. © 2019 Tak Kim.-
dc.languageEnglish-
dc.language.isoen-
dc.publisherKorean Society Clinical Pharmacology and Therapeutics-
dc.subjectestradiol-
dc.subjectfollitropin-
dc.subjectglucose-
dc.subjectluteinizing hormone-
dc.subjectneuroleptic agent-
dc.subjectolanzapine-
dc.subjectoral contraceptive agent-
dc.subjectperphenazine-
dc.subjectprogesterone-
dc.subjectprolactin-
dc.subjectrisperidone-
dc.subjecttestosterone-
dc.subjectthyrotropin-
dc.subjectvenlafaxine-
dc.subjectacute disease-
dc.subjectadult-
dc.subjectamenorrhea-
dc.subjectanger-
dc.subjectanxiety-
dc.subjectArticle-
dc.subjectauditory hallucination-
dc.subjectbleeding-
dc.subjectbloating-
dc.subjectbody mass-
dc.subjectbreast augmentation-
dc.subjectcase report-
dc.subjectclinical article-
dc.subjectclinical evaluation-
dc.subjectconceptual disorganization-
dc.subjectconstipation-
dc.subjectdelusion-
dc.subjectdisease duration-
dc.subjectdisease worsening with drug treatment-
dc.subjectevening dosage-
dc.subjectfemale-
dc.subjectfollow up-
dc.subjecthuman-
dc.subjecthyperprolactinemia-
dc.subjectmenstrual cycle-
dc.subjectmenstruation-
dc.subjectmental disease-
dc.subjectmental instability-
dc.subjectmood-
dc.subjectneuroapoptosis-
dc.subjectovary insufficiency-
dc.subjectparanoia-
dc.subjectpersonal hygiene-
dc.subjectphysical altercation-
dc.subjectPositive and Negative Syndrome Scale-
dc.subjectpsychopharmacology-
dc.subjectpsychosis-
dc.subjectrigidity-
dc.subjectschizophrenia-
dc.subjectself monitoring-
dc.subjectsocial status-
dc.subjectsomnolence-
dc.subjecttremor-
dc.subjectwater retention-
dc.subjectxerostomia-
dc.titleThe problem of medicating women like the men: Conceptual discussion of menstrual cycle-dependent psychopharmacology-
dc.typeArticle-
dc.contributor.affiliatedAuthorKim, T.-
dc.identifier.doi10.12793/tcp.2019.27.4.127-
dc.identifier.scopusid2-s2.0-85079146219-
dc.identifier.bibliographicCitationTranslational and Clinical Pharmacology, v.27, no.4, pp.127 - 133-
dc.relation.isPartOfTranslational and Clinical Pharmacology-
dc.citation.titleTranslational and Clinical Pharmacology-
dc.citation.volume27-
dc.citation.number4-
dc.citation.startPage127-
dc.citation.endPage133-
dc.type.rimsART-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.description.journalRegisteredClassscopus-
dc.description.journalRegisteredClasskci-
dc.subject.keywordPlusestradiol-
dc.subject.keywordPlusfollitropin-
dc.subject.keywordPlusglucose-
dc.subject.keywordPlusluteinizing hormone-
dc.subject.keywordPlusneuroleptic agent-
dc.subject.keywordPlusolanzapine-
dc.subject.keywordPlusoral contraceptive agent-
dc.subject.keywordPlusperphenazine-
dc.subject.keywordPlusprogesterone-
dc.subject.keywordPlusprolactin-
dc.subject.keywordPlusrisperidone-
dc.subject.keywordPlustestosterone-
dc.subject.keywordPlusthyrotropin-
dc.subject.keywordPlusvenlafaxine-
dc.subject.keywordPlusacute disease-
dc.subject.keywordPlusadult-
dc.subject.keywordPlusamenorrhea-
dc.subject.keywordPlusanger-
dc.subject.keywordPlusanxiety-
dc.subject.keywordPlusArticle-
dc.subject.keywordPlusauditory hallucination-
dc.subject.keywordPlusbleeding-
dc.subject.keywordPlusbloating-
dc.subject.keywordPlusbody mass-
dc.subject.keywordPlusbreast augmentation-
dc.subject.keywordPluscase report-
dc.subject.keywordPlusclinical article-
dc.subject.keywordPlusclinical evaluation-
dc.subject.keywordPlusconceptual disorganization-
dc.subject.keywordPlusconstipation-
dc.subject.keywordPlusdelusion-
dc.subject.keywordPlusdisease duration-
dc.subject.keywordPlusdisease worsening with drug treatment-
dc.subject.keywordPlusevening dosage-
dc.subject.keywordPlusfemale-
dc.subject.keywordPlusfollow up-
dc.subject.keywordPlushuman-
dc.subject.keywordPlushyperprolactinemia-
dc.subject.keywordPlusmenstrual cycle-
dc.subject.keywordPlusmenstruation-
dc.subject.keywordPlusmental disease-
dc.subject.keywordPlusmental instability-
dc.subject.keywordPlusmood-
dc.subject.keywordPlusneuroapoptosis-
dc.subject.keywordPlusovary insufficiency-
dc.subject.keywordPlusparanoia-
dc.subject.keywordPluspersonal hygiene-
dc.subject.keywordPlusphysical altercation-
dc.subject.keywordPlusPositive and Negative Syndrome Scale-
dc.subject.keywordPluspsychopharmacology-
dc.subject.keywordPluspsychosis-
dc.subject.keywordPlusrigidity-
dc.subject.keywordPlusschizophrenia-
dc.subject.keywordPlusself monitoring-
dc.subject.keywordPlussocial status-
dc.subject.keywordPlussomnolence-
dc.subject.keywordPlustremor-
dc.subject.keywordPluswater retention-
dc.subject.keywordPlusxerostomia-
dc.subject.keywordAuthorClinical trial design-
dc.subject.keywordAuthorDrug dose-
dc.subject.keywordAuthorMenstrual cycle-
dc.subject.keywordAuthorSchizophrenia-
dc.subject.keywordAuthorSex steroids-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Kim, Tak photo

Kim, Tak
의과대학 (의학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE